歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗HLA-DRB3多克隆抗體
  • 兔抗HLA-DRB3多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW7717
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:20
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱: 兔抗HLA-DRB3多克隆抗體

英文名稱: Anti-HLA-DRB3 rabbit polyclonal antibody

別     名: major histocompatibility complex, class II, DR beta 3; HLA-DR1B; HLA-DR3B

抗     原:
HLA-DRB3

儲     存: 冷凍(-20℃)

宿     主: Rabbit

相關(guān)類別: 一抗

反應(yīng)種屬: Human

標(biāo) 記 物: Unconjugate

克隆類型: rabbit polyclonal


技術(shù)規(guī)格

Background:

HLA-DRB3 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB3 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.

Applications:

ELISA, IHC

Name of antibody:

HLA-DRB3

Immunogen:

Synthetic peptide of human HLA-DRB3

Full name:

major histocompatibility complex, class II, DR beta 3

Synonyms:

HLA-DR1B; HLA-DR3B

SwissProt:

P79483

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human cervical cancer

IHC Recommend dilution:

20-100